Economic evaluation of human papilloma virus vaccination in the European Union: a critical review.


The human papilloma virus (HPV) vaccine is a new and expensive vaccine potentially effective in the prevention of a cancer. We reviewed the economic evaluations (EEs) on the vaccine in the EU to assess their potential contribution to public decision-making in a fairly homogeneous setting where HPV vaccination has been widely adopted. A literature search on… (More)
DOI: 10.1007/s11739-011-0529-3


  • Presentations referencing similar topics